$14K Grant Boosts Heart Health Checks for Mass. Firefighters
Amesbury’s City Council approved a $14,858 grant from the Massachusetts Interlocal Insurance Association to fund cardiac screenings for 17 of the fire department’s 39 members. The grant, secured by Lieutenant David Carpentier, will cover expensive heart‑health evaluations scheduled for late spring. Selections will be on a first‑come, first‑served basis, with plans to expand screenings to the entire crew over the next few years. The approval coincided with First Responder Wellness Week, highlighting the city’s focus on firefighter health.
Oric to Advance Prostate Cancer Drug to Phase 3, but Combo Choice Raises Doubts
Oric Pharmaceuticals announced that its PRC2 inhibitor will move into a registrational Phase 3 trial for prostate cancer after reporting encouraging safety and disease‑control signals in a Phase 1b study. The company plans to evaluate the drug both as a...
Health Care Funding: Information on Crisis Pregnancy Centers, Fiscal Years 2018 Through 2024
The Government Accountability Office identified that the Department of Health and Human Services obligated at least $34 million in federal grants to 16 crisis pregnancy centers (CPCs) between fiscal years 2018 and 2024. CPCs, typically nonprofit and faith‑based, offer free or...
Frontier Medicines Grants Ex-China Rights of FMC-220 to LG Chem
Frontier Medicines has granted LG Chem an exclusive global license to develop and commercialize its covalent p53 Y220C activator FMC-220 outside Greater China, while retaining full rights within that region. LG Chem will manage regulatory filings, global clinical development, and...
WHO Expands TB Diagnostic Toolkit with Point-of-Care Tests, Tongue Swabs, and Sample Pooling
The World Health Organization released new guidelines that introduce near point‑of‑care nucleic acid amplification tests, tongue‑swab specimens, and sputum pooling to speed and broaden TB diagnosis. These tools aim to shift testing to primary‑care settings, lower costs, and improve throughput...
Autistic People Are More Likely to Experience Suicidal Crisis. 988 Is Changing to Serve Them Better
The 988 Lifeline, the nation’s 24‑hour free suicide‑prevention service, has fielded roughly 25 million contacts since its launch in July 2022. Autistic individuals, who are significantly more likely to experience suicidal thoughts, often encounter communication barriers that can turn a crisis call...
Can This Antioxidant Support Ovarian Cancer Treatment? What Research Shows
Researchers reviewed pre‑clinical studies and performed molecular‑docking simulations to assess resveratrol’s interaction with ovarian cancer proteins. The analysis suggests the antioxidant may modulate cell growth, inflammation, hormone signaling, and stress pathways, potentially enhancing the efficacy of chemotherapy and radiation. While...
Patients Know Best and Heartfelt Technologies Collaborate to Accelerate Clinical Trial Recruitment
Patients Know Best teamed with Heartfelt Technologies to automate recruitment for the Innovate UK‑funded HF‑TRACK trial, enrolling 16 participants in just four weeks—a 135% increase over the trial’s average rate. The partnership leveraged PKB’s coded health‑record data to display a...
Reimagining High-Acuity Care: The Role of AI in Neurological Patient Pathways
High‑acuity neurological care is grappling with massive data streams and fragmented handoffs, prompting a push for AI‑driven decision support and unified digital pathways. Machine‑learning models now analyze multimodal ICU inputs to flag early deterioration and streamline imaging interpretation. Yet the...
Here Is Why Ocular Therapeutix (OCUL) Is Highly Favored by Hedge Funds
Ocular Therapeutix (OCUL) received upgraded price targets from Bank of America and Clear Street, raising them to $27 and $28 respectively while maintaining Buy ratings. Both firms highlighted the Phase 3 SOL‑1 trial, which demonstrated durable control of wet age‑related macular...
Wearable AI Devices Market Insights Report 2026-2036 Featuring Strategic Analysis of Apple, Samsung Electronics, Google, Huawei Technologies Co., Sony Corp....
The global wearable AI devices market is projected to surge from $69.8 billion in 2026 to about $270.2 billion by 2036, delivering a 14.5% compound annual growth rate. Smartwatches dominate the market today, while eye‑wear is set to post the fastest growth...
Yes, GLP-1s Are Changing What Food People Buy — Here's How
GLP‑1 drugs such as Ozempic and Wegovy are prompting measurable changes in grocery purchasing patterns. A Danish study of 1,177 adults, covering nearly two million transactions, found that users bought foods with slightly lower calories, sugar, carbohydrates and saturated fat,...
ACC 2026: Sotatercept Shows Signal in CpcPH-HFpEF at Lower Dose
At the 2026 ACC Scientific Session, the phase‑II CADENCE trial showed that sotatercept (WINREVAIR) reduced pulmonary vascular resistance in adults with combined post‑ and precapillary pulmonary hypertension linked to HFpEF (CpcPH‑HFpEF). The study randomized 164 patients, median age 75, to...
Development And Validation Of Prognostic Scale In Respiratory Condition for Physiotherapist in ICU
Researchers have designed and validated a prognostic scale tailored for physiotherapists treating respiratory conditions in intensive care units. The scale achieved a content validity ratio of 0.846, indicating strong reliability, while Cohen’s kappa testing demonstrated perfect inter‑rater agreement (p < 0.05). Validation...
Treating Arthritis of the Hands
Arthritis of the hands, wrists and fingers—most commonly osteoarthritis, rheumatoid arthritis, or post‑traumatic arthritis—affects millions and can severely limit daily function. Dr. Kevin Chung of the University of Michigan Health explains that early diagnosis through imaging or labs enables a...
Developing Patient-Reported Outcome Measures of Timely Experience of Diagnosis (PROMOTE-Dx) for Cancer
The research team released PROMOTE‑Dx, a validated patient‑reported outcome measure that captures the timeliness of cancer diagnosis. The instrument was created through extensive survey development, cognitive testing, and psychometric validation. PROMOTE‑Dx is designed for health‑care systems and insurers to monitor...
Trump’s One Big Beautiful Bill Act Darkens Outlook for Government-Backed Clinics
Nebraska will become the first state to implement the work‑requirement provisions of President Trump’s One Big Beautiful Bill Act, forcing certain Medicaid expansion enrollees to prove 80 hours of work or volunteer each month. Bluestem Health, a safety‑net clinic in Lincoln serving 21,000...
Quality Care Collaboratives for Maternal Health Across U.S. States
A new scoping review will map how state‑based maternal and perinatal quality collaboratives (M/PQCs) implement safety toolkits and bundles across U.S. health systems. The review will include studies published after 2000, drawing from MEDLINE, Embase, CINAHL, the Maternity and Infant...
A Longitudinal Multi‑proxy Geospatial Classification of Peri‑urban Transitions Across Community Health Units in Coastal Kenya
The study applied five publicly available geospatial proxies to classify settlement dynamics across ten Community Health Units in coastal Kenya from 2017 to 2024. Median cumulative changes were 62% for nighttime lights, 111% for Sentinel‑2 built‑up, 34% for WorldPop built‑up,...
MediBeacon Secures CE Mark Certification for TGFR Monitor and Sensor
MediBeacon announced that its transdermal glomerular filtration rate (TGFR) monitor and reusable sensor have earned CE Mark certification under the EU Medical Device Regulation. The Class IIa devices, part of the broader TGFR system that includes the Lumitrace injection and disposable...
Symeres and Ambagon Collaborate for Colorectal Cancer Molecules
Symeres has partnered with Ambagon Therapeutics to evaluate molecular‑glue compounds for colorectal cancer. The collaboration will leverage Symeres’ in‑vitro assays, surface‑plasmon resonance kinetics, and fluorescence microscopy to characterize ternary‑complex formation and downstream pathway effects. Symeres will also profile each candidate...
Symeres and Ambagon Collaborate for Colorectal Cancer Molecules
Symeres has partnered with Ambagon Therapeutics to evaluate Ambagon’s molecular glue candidates for colorectal cancer. The collaboration will use Symeres’ in‑vitro assays, surface plasmon resonance, fluorescence microscopy and a 102‑cell line panel to characterize ternary complex kinetics and downstream pathway...
STAT+: The Biotech Scorecard for the Second Quarter: 23 Stock-Moving Events to Watch
STAT’s quarterly biotech scorecard lists 23 upcoming events that could move biotech stocks in Q2 2026. Highlights include Phase 3 results from Abivax’s obefazimod in ulcerative colitis and Allogene Therapeutics’ interim data on its cema‑cel CAR‑T therapy for B‑cell lymphoma. The...
Lilly Moves Deeper Into Sleep Medicine with up to $7.8 Billion Centessa Deal
Eli Lilly announced a definitive agreement to acquire UK‑based Centessa Pharmaceuticals for up to $7.8 billion, paying $38 per share in cash and up to $9 per share in contingent milestones. The acquisition gives Lilly control of Centessa’s orexin‑receptor‑2 agonist pipeline,...
‘We’re Failing Newborns’: The Global Push to Reduce Infant Deaths Is Losing Steam
The United Nations’ 2030 goal to cut neonatal mortality to 12 per 1,000 live births is slipping, with more than 60 countries—especially in Africa—far off track. Neonatal deaths remain at 2.3 million annually, driven by prematurity, asphyxia, and infections, while power...
Anavex Updates Regulatory Strategy for Blarcamesine
Anavex Life Sciences has withdrawn its European Union marketing authorization application for blarcamesine and will collect additional data while maintaining dialogue with the European Medicines Agency. The company has concurrently submitted new data to the U.S. FDA to explore a...
Insilico Medicine, Lilly Partner on AI-Driven Drug Discovery Deal
Insilico Medicine and Eli Lilly have entered a partnership to use Insilico’s AI‑driven Pharma.AI platform for discovering new oral therapeutics across several disease areas. Lilly receives an exclusive worldwide license to develop, manufacture and commercialize the preclinical candidates, while Insilico secures...
Radiologists Urge Medicare Contractor to Exempt Professional Component From New Pay Restriction
Radiologists, backed by the RBMA and ACR, have asked Noridian Healthcare Solutions to exempt the professional component of CPT 74177 (CT abdomen/pelvis with contrast) and CPT 72148 (MRI spine without contrast) from a new pre‑payment review. Noridian instituted the review citing high...
How Outsourcing Solves the Chronic Shortage of Specialized DME Billing Talent
The durable medical equipment (DME) sector faces a deepening shortage of specialized billing professionals, driven by retirements, high turnover and escalating salary demands. In‑house recruitment struggles to keep pace, leading to longer claim cycles, higher denial rates and financial strain....
New Data Show TrenibotE Safety in Repeat Treatments
Allergan Aesthetics presented new Phase 3 data on its investigational neurotoxin TrenibotE at the 2026 American Academy of Dermatology meeting. The open‑label study evaluated up to three repeat glabellar line treatments, confirming a consistent safety profile, no neutralizing antibodies, rapid onset...
Elidah Reports US FDA Clearance of Elitone for Men to Treat Post-Prostatectomy Urinary Incontinence
Elidah announced that the U.S. Food and Drug Administration has cleared its at‑home device, Elitone for Men, to treat urinary incontinence after prostate surgery. The non‑invasive system delivers neuromuscular stimulation to the pelvic floor for a 20‑minute daily session, eliminating...
Distalmotion Targets ASC Robotic Gynecology Programs with FDA Filing
Distalmotion has filed a 510(k) request to add sacrocolpopexy, sacrocervicopexy and endometriosis resection to the FDA‑cleared indications for its Dexter robotic system. The move targets ambulatory surgical centers, where the robot’s small footprint could out‑compete larger platforms. The company recently...
The Brave New World of Radiotherapeutics
Radiotherapeutics have moved from niche concepts to a burgeoning oncology platform, driven by unmet treatment gaps and the commercial breakthrough of Novartis' Pluvicto. Early data show Actinium‑225 delivering 45‑50% response rates in heavily pre‑treated prostate cancer, while Bayer's Xofigo adds...
Looking Into the Continuing Costs of India’s COVID-19 Policy
India’s COVID‑19 response left a staggering human toll, with the Registrar General reporting 1.02 crore (≈10.2 million) deaths in 2021—a 25.9% jump over 2020. Three recent books document the pandemic’s clinical, logistical, and personal dimensions, highlighting rail shutdowns, oxygen shortages, and the...
What Disrupts Continuity of Care in Assisted Living Facilities?
Continuity of care is the backbone of assisted‑living operations, linking medical oversight with the emotional stability residents depend on. When care pathways fracture, outcomes such as medication errors, falls, and resident dissatisfaction rise sharply, prompting higher regulatory scrutiny and reputational...
Africa Turns to Philanthropists to Fill Gaps in Health Funding
With international aid shrinking, African governments are turning to philanthropic capital to bridge widening health‑care gaps. The Bill & Melinda Gates Foundation announced a $200 bn spend‑down by 2045, prioritising primary care, data systems and AI‑driven services across the continent. Corporate...
AskBio Announces Completion of Enrollment in Phase 2 Clinical Trial of AB-1002 Investigational Gene Therapy for Heart Failure
AskBio, a Bayer subsidiary, announced that enrollment for its GenePHIT Phase 2 trial of the investigational gene therapy AB‑1002 has been completed, randomizing 173 patients with non‑ischemic cardiomyopathy and NYHA Class III heart‑failure symptoms. The trial, spanning 46 sites across North America...
How Rural Health Systems Are Advancing Cardiac Imaging
Rural health systems are deploying cardiac CT scanners to bring high‑resolution, non‑invasive heart imaging to underserved areas. The technology delivers scans in about 15 minutes, enabling clinicians to avoid invasive catheterizations for 77% of patients and cut diagnostic costs by...
Beyond Reimbursement: Why Market Access Is MedTech’s Strategic North Star
The article argues that Market Access (MA) has moved beyond a narrow reimbursement focus to become a strategic engine for MedTech firms. Insights from BCG roundtables and industry leaders highlight new MA capabilities—experts, stewards, and integrators—that drive product adoption, pricing...
HHS Unveils MANA Plan
On April 1, 2026, the U.S. Department of Health and Human Services (HHS) unveiled a new initiative dubbed the MANA plan, short for “Make America Normal Again.” The announcement was delivered by HHS Secretary Robert F. Kennedy Jr. during a briefing at the...
How GLP-1 Is Impacting Food and Beverage Consumption in Australia
GLP-1 receptor agonists, originally developed for type‑2 diabetes, are rapidly being prescribed for weight management in Australia, with about 500,000 users today and projections that 10% of the population could be on the drugs by 2030. Their appetite‑suppressing effect is...
From Data to Discovery: Inside the Bio-IT Hackathon
The Bio‑IT World Hackathon, hosted by the NIH Common Fund Data Ecosystem Training Center, gathered multidisciplinary teams to tackle six real‑world biomedical data challenges using cloud‑based AI tools. Participants, ranging from students to industry professionals, had 48 hours to develop...
University of Toledo Health to Deploy Nabla’s Ambient AI Documentation in Epic EHR
University of Toledo Health is rolling out Nabla’s ambient AI clinical assistant to hundreds of physicians and advanced practice providers, embedding the technology directly into Epic’s electronic health record. The AI listens to doctor‑patient conversations and auto‑generates structured notes, cutting...
What Does It Mean To Be ‘California Sober’?
The "California sober" approach promotes swapping high‑risk substances such as alcohol, opioids, or stimulants for moderate cannabis use, positioning itself as a harm‑reduction alternative to total abstinence. Proponents cite greater control, smoother withdrawal, and improved daily functioning, while critics warn...
The Role of Ethical Oversight and Algorithmic Bias in Automated Pharmacovigilance
Pharmacovigilance is rapidly adopting machine learning, natural language processing, and automation to ingest, categorize, and prioritize adverse event reports, dramatically shrinking backlogs and accelerating signal detection. While these technologies deliver speed and scale, they also inherit reporting biases and can...
Philips Issues Urgent Device Correction Notice for Thousands of Imaging Units
Philips Healthcare has issued an urgent correction notice for its Allura and Azurion interventional fluoroscopy systems after discovering a foot‑switch design flaw that can prevent or intermittently enable X‑ray imaging. The U.S. FDA classified the issue as a Class 2 recall,...
Rights Group Report Identifies Alternatives to Mental Health Crisis Response in US
Human Rights Watch released a report identifying 150 non‑police mental‑health crisis programs across the United States, with eight detailed case studies such as Oakland’s Mobile Assistance Community Responders and Cambridge’s Holistic Emergency Alternative Response Team. The report finds that removing...
:max_bytes(150000):strip_icc():format(jpeg)/zoloft-overdose-1067483_final-f8bf664ae4ac495eab04b736c0c00ed1.png)
Symptoms of a Zoloft Overdose
Zoloft (sertraline) overdoses can produce a spectrum of symptoms from mild dizziness and nausea to severe serotonin syndrome, seizures, and cardiac issues. The article emphasizes immediate contact with the national Poison Control hotline (1‑800‑222‑1222) and outlines emergency interventions such as...
Healthcare Moves: A Monthly Summary of Hires, Exits and Layoffs
April’s healthcare talent roundup shows a wave of tech‑savvy hires, with Advocate Health tapping a former Verily chief and Artera appointing an ex‑Amazon CTO. Cigna announced its long‑time COO Brian Evanko will take over as CEO, while several seasoned leaders...
Nihon PMI Partners on Tapping Into Japan’s Home-Based Healthcare Market
Nihon PMI Partners announced a strategic push into Japan’s rapidly expanding home‑based healthcare sector. CEO Satoshi Hamada highlighted that the nation’s aging population and a policy‑driven shift from hospital to community care are creating sizable investment openings. The firm plans...